Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients

被引：32

作者：

Gené, J

Azón-Masoliver, A

Guarro, J

De Febrer, G

Martínez, A

Grau, C

Ortoneda, M

Ballester, F

机构：

[1] Univ Rovira & Virgili, Fac Med & Ciencies Salut, Hosp Univ Sant Joan, Unitat Microbiol, Tarragona 43201, Spain

[2] Univ Rovira & Virgili, Unitat Dermatol, Hosp Univ Sant Joan, Tarragona 43201, Spain

[3] Univ Rovira & Virgili, Unitat Sociosanitaria, Hosp Univ Sant Joan, Tarragona 43201, Spain

[4] Univ Rovira & Virgili, Unitat Anat Patol, Hosp Univ Sant Joan, Tarragona 43201, Spain

[5] Univ Rovira & Virgili, Unitat Microbiol, Hosp Univ Sant Joan, Tarragona 43201, Spain

[6] Univ Rovira & Virgili, Inst Estudis Avancats, Tarragona 43201, Spain

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2001年 / 39卷 / 03期

关键词：

D O I：

10.1128/JCM.39.3.1134-1136.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We report a case of primary cutaneous infection by the emerging fungus Aspergillus ustus in an immunosuppressed patient after a domestic accident. The patient failed to respond to itraconazole and died before receiving a new treatment with amphotericin B. There have been eight other cases reported since 1973, and only two patients survived the infection. In vitro susceptibility testing of seven antifungal drugs showed that terbinafine and the new azole derivative UR-9825 were the most active against this fungus.

引用

页码：1134 / 1136

页数：3

共 9 条

[1]

de Hoog GS, 1995, Atlas of clinical fungi, V1st

[2]

GAMS W, 1985, NATO ASI SERIES A, V102, P55

[3]

National Committee for Clinical Laboratory Standards, 1998, M38P NAT COMM CLIN L

[4]

Odds FC, 1998, ANTIMICROB AGENTS CH, V42, P282